Your cat was diagnosed with Mediastinal Lymphoma. Often associated with FeLV infection, particularly in young cats. Siamese cats may develop FeLV-negative form. Presents with pleural effusion and respiratory distress. Compare 9 treatment options for cats including COP Protocol, CHOP Protocol, L-Asparaginase Induction — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Mediastinal Lymphoma
Feline Oncology Treatment Guide
Mediastinal Lymphoma
mediastinal
Round Cell
About This Cancer
Mediastinal lymphoma arises from the thymus gland or lymph nodes in the mediastinum — the central compartment of the chest between the lungs. It is strongly associated with feline leukaemia virus (FeLV) infection, particularly in young cats. The tumour typically consists of malignant T-lymphocytes and grows as a large mass in the chest cavity, often causing fluid to accumulate around the lungs (pleural effusion). Affected cats present with difficulty breathing, sometimes quite suddenly and severely. Siamese cats can develop a FeLV-negative form. Chemotherapy can produce meaningful remission in some cases, and FeLV-negative cats generally have a better response than FeLV-positive cats. The condition is primarily seen in younger cats (typically between 2 and 5 years of age), in contrast to most other feline lymphoma types which tend to affect older cats.
WHO Modified Staging for Feline Lymphoma
Standard feline lymphoma staging. Mediastinal lymphoma typically presents as Stage I (single extranodal site) or higher if disseminated.
Prognostic Factors(5)
Minimum Workup(9 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.